Hbk Investments L P Bristol Myers Squibb CO Transaction History

Hbk Investments L P

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $621,809 - $690,422	9,760 New	9,760 $624,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $960,109 - $1.06 Million	-13,221 Reduced 78.24%	3,677 $283,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $4.85 Million - $5.82 Million	-78,936 Reduced 82.37%	16,898 $1.23 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1.64 Million - $1.86 Million	28,372 Added 42.06%	95,834 $5.95 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $366,460 - $406,086	-6,381 Reduced 8.64%	67,462 $4.07 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $662,444 - $774,463	12,084 Added 19.57%	73,843 $4.34 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $27.7 Million - $40.3 Million	-597,707 Reduced 90.63%	61,759 $3.44 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $17.6 Million - $20.9 Million	389,302 Added 144.1%	659,466 $31.5 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $3.27 Million - $4.24 Million	67,041 Added 33.01%	270,164 $14 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $27.1 Million - $30.5 Million	-490,134 Reduced 70.7%	203,123 $12.6 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $21 Million - $26.2 Million	415,802 Added 149.86%	693,257 $38.4 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $10.6 Million - $12.2 Million	176,755 Added 175.53%	277,455 $17.5 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $6.04 Million - $6.58 Million	100,700	100,700 $6.17 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.